» Articles » PMID: 35069213

Sources of Information on Medicinal Products Among Physicians - A Survey Conducted Among Primary Care Physicians in Poland

Overview
Journal Front Pharmacol
Date 2022 Jan 24
PMID 35069213
Authors
Affiliations
Soon will be listed here.
Abstract

Primary care physicians need to have access to up-to-date knowledge in various fields of medicine and high-quality information sources, but little is known about the use and credibility of sources of information on medicinal products among Polish doctors. The main goal of this study was to analyze the sources of information on medicinal products among primary care physicians in Poland. A survey was conducted among 316 primary care physicians in Poland. The following information was collected: demographic data of participants, type and frequency of using data sources on medicinal products, barriers to access credible information, assessment of the credibility of the sources used, impact of a given source and other factors on prescription decisions. The most frequently mentioned sources of information were medical representatives (79%), medical journals (78%) and congresses, conventions, conferences, and training (76%). The greatest difficulty in finding the latest information about medicinal products was the lack of time. The surveyed doctors considered clinical guidelines to be the most credible source of information, and this source also had the greatest impact on the choice of prescribed medicinal products. The study showed that clinicians consider clinical guidelines as the most credible source of information with the greatest impact on prescribing medicinal products. However, it is not the source most often mentioned by doctors for obtaining knowledge about medicinal products. There is a need to develop strategies and tools to provide physicians with credible sources of information.

Citing Articles

Drug information-seeking behaviour among Jordanian physicians: a cross-sectional study.

Al Zoubi S, Gharaibeh L, Amaireh E, Khlaifat G, Khalayla H, Obeid S Front Pharmacol. 2023; 14:1264794.

PMID: 38026931 PMC: 10679432. DOI: 10.3389/fphar.2023.1264794.


One year of digital health applications (DiGA) in Germany - Rheumatologists' perspectives.

Richter J, Chehab G, Stachwitz P, Hagen J, Larsen D, Knitza J Front Med (Lausanne). 2022; 9:1000668.

PMID: 36388899 PMC: 9640713. DOI: 10.3389/fmed.2022.1000668.

References
1.
Cook D, Sorensen K, Wilkinson J, Berger R . Barriers and decisions when answering clinical questions at the point of care: a grounded theory study. JAMA Intern Med. 2013; 173(21):1962-9. DOI: 10.1001/jamainternmed.2013.10103. View

2.
Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C . Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Front Pharmacol. 2014; 5:106. PMC: 4060455. DOI: 10.3389/fphar.2014.00106. View

3.
Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier J . Ongoing pharmaceutical reforms in France: implications for key stakeholder groups. Appl Health Econ Health Policy. 2009; 8(1):7-24. DOI: 10.1007/BF03256162. View

4.
Sackett D, Rosenberg W, Gray J, Haynes R, Richardson W . Evidence based medicine: what it is and what it isn't. BMJ. 1996; 312(7023):71-2. PMC: 2349778. DOI: 10.1136/bmj.312.7023.71. View

5.
Carlsen B, Norheim O . "What lies beneath it all?"--an interview study of GPs' attitudes to the use of guidelines. BMC Health Serv Res. 2008; 8:218. PMC: 2577651. DOI: 10.1186/1472-6963-8-218. View